Dr. David Samadi, top prostate cancer surgeon, is pleased to announce new guidelines supporting the federal government’s commitment to faster approval of experimental cancer drugs. New therapies are being designed to target the origin of certain cancers, such as breast cancer and prostate cancer, based on genetic differences and empowering the body’s own defense system. Dr. Samadi believes a shorter approval process could also mean more affordable cancer drug treatments.<br />www.smart-surgery.com
